secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001493152-24-025269
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma annual meeting elects all four directors, ratifies auditor
-----------------------------------------------------------------------

- Quorum: 691,084 shares (50.05%) represented at June 25 annual meeting.
- All four directors elected: Breen (298,002 for), Shrotriya (295,782), Wendel (229,004), Casamento (266,456).
- Ratification of Weinberg & Company as auditor: 579,726 for, 89,595 against, 21,763 abstain.
- Non-binding advisory vote on executive compensation approved: 277,591 for, 47,062 against, 6,392 abstain, 360,039 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315224025269/0001493152-24-025269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315224025269/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer